545
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Proteomic analysis of mouse thymoma EL4 cells treated with bis(tri-n-butyltin)oxide (TBTO)

, , , , , & show all
Pages 174-183 | Received 26 Mar 2009, Accepted 18 May 2009, Published online: 25 Jun 2009

References

  • Ajit, S., and Paul, S. 2002. Involvement of mitogen-activated protein kinases in the signal transduction pathway of bone marrow-derived macrophage activation in response to in vitro treatment with thymosin-α1. Int. Immunopharmacol. 2:47–58.
  • Aluoch, A. O., Odman-Ghazi, S. O., and Whalen, M. M. 2006. Alteration of an essential NK cell signaling pathway by low doses of tributyltin in human natural killer cells. Toxicology 224:229–237.
  • Aragno, M., Mastrocola, R., Medana, C., Catalano, M.G., Vercellinatto, I., Danni, O., and Bocuzzi, G. 2006. Oxidative stress-dependent impairment of cardiac specific transcription factors in experimental diabetes. Endocrinology 147:5967–5974.
  • Baken, K.A., Pennings, J.L.A., de Vries, A., Breit, T.M., van Steeg, H., and van Loveren, H. 2006. Gene expression profiling of bis(tri-n-butyltin)oxide (TBTO)-induced immunotoxicity in mice and rats. J. Immunotoxicol. 3:227–244.
  • Baken, K. A., Arkusz, J., Pennings, J.L.A., Vandebriel, R.J., and van Loveren, H. 2007. In vitro immunotoxicity of bis(tri-n-butyltin)oxide (TBTO) studied by toxigenomics. Toxicology 237:35–48.
  • Barbini, L., Gonzalez, R., Dominguez, F., and Vega, F. 2006. Apoptic and proliferating hepatocytes differ in prothymosin-α expression and cell localization. Mol. Cell. Biochem. 291:83–91.
  • Beneke, R., Bihn, D., Hütler, M., and Leithäuser, R. M. 2005. Hemolysis caused by alterations of α- and β-spectrin after 10 to 35 min of severe exercise. Eur. J. Appl. Physiol. 95:307–312.
  • Bressa, G., Hinton, R. H., Price, S. C., Isbir, M., Ahmed, R. S., and Grasso, P. 1991. Immunotoxicity of tri-n.butyltin oxide TBTO) and tri-n-butyltin chloride (TBTC) in the rat. J. Appl. Toxicol. 11:397–402.
  • Blondeau, F., Ritter, B., Allaire, P., Wasiak, S., Girad, M., Hussain, N. K., Angers, A., Legendre-Guillemin, V., Roy, L., Boismenu, D., Kearney, R. E., Bell, A. W., Bergeron, J. M., and McPherson, P. S. 2004. Tandem MS analysis of brain clathrin-coated vesicles reveals their critical involvement in synaptic vesicle recycling. Proc. Nat. Acad. Sci. USA 101:3833–3838.
  • Boyer I. J. 1989. Toxicity of dibutyl, tributyl and other organotins to humans and to experimental animals. Toxicology 55:253–298.
  • Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein dye binding. Anal. Biochem. 72:248–254.
  • Chow, S. C., and Orrenius, S. 1994. Rapid cytoskeleton modification in thymocytes induced by the immunotoxicant tributyltin. Toxicol. Appl. Pharmacol. 127:19–26.
  • Cordero, O. J., Sarandeses, C. S., Lopez, J. L., and Nogueira, M. 1990. Phytohemagglutin-stimulated human T-cell: Prothymosin-α as an accessory signal. J. Biol Regul. Homeostatic Agents 2:7–12.
  • Cordero, O. J., Sarandeses, C. S., Lopez, J. L., and Nogueira, M. 1992. Prothymosin-α enhances human natural killer cell cytotoxicity: Role in mediating signals for NK activity. Lymphokine Cytokine Res. 11:277–285.
  • Cordero, O. J., Sarandeses, C. S., Lopez, J. L., and Nogueira, M. 1992. On the anomalous behavior on gel-filtration and SDS-electrophoresis of prothymosin-alpha. Biochem. Int. 28:1117–1124.
  • De Waal, E.J., Schuurman, H. J., van Loveren, H., and Vos, J. G. 1997. Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin, bis(tri-n-butyltin)oxide, and cyclosporine on thymus histophysiology. Crit. Rev. Toxicol. 27:381–430.
  • De Waal, E. J., Schuurman, H. J., van Loveren, H., and Vos, J. G. 1993. The cortical epithelium of the rat thymus after in vivo exposure to bis(tri-n-butyltin)oxide (TBTO). An (immuno) histological and ultrastructural study. Arch. Toxicol. 67:186–192.
  • Eckert, K., Garbin, F., Maurer, H. R., Büttner, P., Garbe, C., and Czarnecki, J. 1995. Prothymosin-α modulates lymphokine-activated killer cell activity and IL-2 production by peripheral blood lymphocytes from melanoma patients in vitro. Int. J. Immunopharmacol. 17:555–561.
  • Eckert, K., Grünberg, E., Immenschuh, P., Garbin, F., Kreuser, E. D., and Maurer, H. R. 1997. Interleukin-2-activated killer cell activity in colorectal tumor patients: Evaluation of in vitro effects by prothymosin Eckert, K α 1. Cancer Res. Clin. Oncol. 123:420–428.
  • El-Darahali, A., Fawcett, H., Mader, J. S., Conrad, D. M., and Hoskin, D. W. 2005. Adenosine-induced apoptosis in EL-4 thymoma cells is caspase-independent and mediated through a non-classical adenosine receptor. Exp. Mol. Pathol. 79:249–258.
  • Evstafieva, A. G., Belov, G. A., Kalkum, M., Chichkova, N. V., Bogdanov, A. A., Agol, V. I., and Vartapetian, A. B. 2000. Prothymosin-α fragmentation in apoptosis. FEBS Lett. 467:150–154.
  • Filipeanu, C. M., Zhou, F., Claycomb, W. C., and Wu, G. 2004. Regulation of the cell surface expression and function of angiotensin II type 1 surface receptor by rab1a-mediated endoplasmic reticulum-to-Golgi transport in cardiac myocytes. J. Biol. Chem. 279:41077–41084.
  • Funahashi, N., Iwasaki, I., and Ide, G. 1980. Effects of bis-(tri-n-butyltin)oxide on endocrine and lymphoid organs of male rats. Acta Pathol. Japan 30:955–966.
  • Gao, J. I., Opiteck, G. J., Friedrichs, M. S., Dongre, A. R., and Hefta, S. A. 2003. Changes in the protein expression of yeast as a function of carbon source. J. Proteome Res. 2:643–649.
  • Gao, J. I., Friedrichs, M. S., and Dongre, A. R. 2006. Guidelines for the routine application of the peptide of the peptide hits technique. J. Am. Soc. Mass Spec. 16:1231–1238.
  • Garbin, F., Eckert, K., Büttner, P., Garbe, C., and Maurer, H. R. 1994. Prothymosin-α augments deficient anti-tumor activity of monocytes from melanoma patients in vitro. Anticancer Res. 14:2405–2412.
  • Garbin, F., Eckert, K., Immenschuh, P., Kreuser, E. D., and Maurer, H. R. 1997. Prothymosin-α1 effects in vitro on the anti-tumor activity and cytokine production of blood monocytes from colorectal tumor patients. Int. J. Immunopharmacol. 19:323–332.
  • Gast, K., Damaschun, H., Eckert, K., Schulze-Forster, K., Maurer, H. R., Müller-Frohne, M., Zirwer, D., Czarneccki, J., and Damaschun, G. 1995. Prothymosin-α: A biologically-active protein with random coil conformation. Biochemistry. 34:13211–13218.
  • Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A., and Enright, A. J. 2006. miRBAse: MicroRNA sequences, targets, and gene nomenclature. Nucl. Acids Res. 34 (DATABASE ISSUE):D140–D144.
  • Gennari, A., Potters, M., Seinen, W., and Pieters, R. 1997. Organotin-induced apoptosis as observed in vitro is not relevant for induction of thymus atrophy at anti-proliferative doses. Toxicol. Appl. Pharmacol. 147:259–266.
  • Gennari, A., Viviani, B., Galli, C.L., Marinovich, M., Pieters, R., and Corsini, E. 2000. Organotins induce apoptosis by disturbing [Ca+2] and mitochondrial activity, causing oxidative stress and activation of caspases in rat thymocytes. Toxicol. Appl. Pharmacol. 169:185–190.
  • Grote, K., Stahlschmidt, B., Talsness, C. E., Gericke, C., Appel, K. E., and Chahoud, I. 2004. Effects of organotin compounds on pubertal male rats. Toxicology 202:145–158.
  • Grünberg, E., Eckert, K., and Maurer, H. R. 1997. Prothymosin-α1 enhances the interleukin-2 activated killer cell adhesion to and immunotoxicity against docetaxel-treated HT-29 colon carcinoma cells in vitro. Int. J. Thymol. 5:415–423.
  • Haritos, A. A., Blacher, R., Stein, S., Caldarella, J., and Horecker, B. L. 1985. Primary structure of rat thymus prothymosin-α. Proc. Natl. Acad. Sci. USA 82:343–346.
  • Heneweer, M., Houtman, R., Poortman, J., Groot, M., Maliepaard, C., and Peinenburg, A. 2007. Estrogenic effects in the immature rat uterus after dietary exposure to ethinylestradiol and zearalenone using a systems biology approach. Toxicol. Sci. 99:303–314.
  • Hentze, M. W. 1997. eIF4G: A multipurpose ribosome adaptor. Science 275:500–501.
  • Jensen, K. G., önfelt, A., Wallin, M., Lidums, V., and Andersen, O. 1991. Effects of organotin compounds on mitosis, spindle structure, toxicity and in vitro microtubule assembly. Mutagenesis 6:409–416.
  • Kannan, K., Corsolini, S., Focardi, S., Tanabe, S., and Tatsukawa, R. 1996. Accumulation pattern of butyltin compounds in dolphin, tuna, and shark collected from Italian coastal waters. Arch. Environ. Contam. Toxicol. 35:64–69.
  • Karesuo, Z., Sandaltzopoulos, R., Frangou-Lazaridis, M., Lai, C. Y., Tsolas, O., Becker, P. B., and Papamarcaki, T. 1998. Prothymosin-α modulates the interaction of histone 1 with chromatin. Nucl. Acid Res. 26:3111–3118.
  • Karapetian, R. N., Evstafieva, A. G., Abaeva, I. S., Chichkova, N. V., Filonov, G. S., Rubtsov, Y. P., Sukhacheva, E. A., Melnikov, S. V., Schneider, U., Wanker, E. E., and Vartapetian, A. B. 2005. Nuclear oncoprotein prothymosin-α is a partner of keap1: Implications for expression of oxidative-stress protecting genes. Mol. Cell. Biol. 25:1089–1099.
  • Lee, C. Y., Wey, S. P., Liao, M. H., Hsu, W. L., Wu, H. Y., and Jan, T. R. 2008. A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells. Int. Immunopharmacol. 8:732–740.
  • Li, J., Steen, H., and Gygi, S. P. 2003. Protein profiling with cleavable isotope coded affinity Tag (cICAT) reagents: The yeast salinity stress response. Mol. Cell. Proteom. 2:1198–1204.
  • Li S., Ouyang, Y., Yang, G. H., and Pestka, J. J. 2000. Modulation of transcription factor AP-1 activity in murine EL-4 thymoma cells by vomitoxin (deoxynivalenol). Toxicol. Appl. Pharmacol. 163:17–25.
  • Marinovich, M., Sanghvi, A., Colli, S., Tremoli, E., and Galli, C. L. 1990. Cytoskeleton modifications induced by organotin compounds in human neutrophils. Toxicol. In Vitro 4:109–113.
  • Meiring, H. D., Van Der Heeft, E., Ten Hove, G. J., and De Jong, A. P. 2002. Nanoscale LC_MS(n): Technical design and applications to peptide and protein analysis. J. Sep. Sci. 25:557–568.
  • Nagy, Z. S. 1999. Neuronal death in Down’s syndrome. J. Neur. Trans. 57:233–245.
  • Nuoffer, C., Davidson, H. W., Matteson, J., Meinkoth, J., and Balch, W. E. 1994. A GDP-bound form of rab1a inhibits protein export from the endoplasmic reticulum and transport between Golgi compartments. J. Cell Biol. 125:225–237.
  • Osmanagic-Myers, S., and Wiche, G. 2004. Plectin-Rack1 (receptor for activated kinase 1) scaffolding. A novel mechanism to regulate protein kinase activity. J. Biol. Chem. 279:18701–18710.
  • Pálmer, H. G., Carbayo, M. S., Morán, P. O., and Larriba, M. J. 2003. Genetic signatures of differentiation induced by 1α, 2,5-dihyroxyvitamin D3 in human colon cancer cells. Cancer Res. 63:7799–7806.
  • Palvimo, J., and Linnala-Kankkunen, A. 1990. Identification of a low-Mr acidic nuclear protein as prothymosin α. FEBS Lett. 277:257–260.
  • Pang, J. X., Ginanni, N., Dongre, A. R., Hefta, S. A., Opiteck, G. J. 2002. Biomarker discovery in urine by proteomics. J. Proteome Res. 1:161–169.
  • Papamarcaki, T., and Tsolas, O. 1994. Prothymosin α binds to Histone H1 in vitro. FEBS Lett. 345:71–75.
  • Pei, L. 1999. Pituitary tumor-transforming gene protein associates with ribosomal protein 10S and a novel human homologue of DnaJ in testicular cells. J. Biol. Chem. 274:3151–3158.
  • Pind, S. N., Nuoffer, C., McCaffery, J. M., Plutner, H., Davidson, H. W., Farquhar, M. G., and Balch, W.E. 1994. Rab1a and Ca2+ are required for the fusion of carrier vesicles mediating endoplamic reticulum to Golgi transport. J. Cell Biol. 125:239–252.
  • Raffray, M., and Cohen, G. M. 1991. Bis(tri-n-butyltin)oxide induces cell death apoptosis in immature rat thymocytes. Arch. Toxicol. 65:135–139.
  • Raffray, M., and Cohen, G. M. 1993. Thymocyte apoptosis as a mechanism for tributyltin-induced thymic atrophy in vivo. Arch. Toxicol. 67:231–236.
  • Rappsilber, J., Ryder, U., Lamond, A. I., and Mann, M. 2002. Large-scale proteomic analysis of the human spliceosome. Genome Res. 12:1231–1245.
  • Sburlati, A. R., Manrow, R. E., and Berger, S. L. 1991. Prothymosin-α antisense oligomers inhibit myeloma cell division. Proc. Natl. Acad. Sci. USA 88:253–257.
  • Schrantz, J. 1990. TBTO marine paint under EPA scrutiny. Ind. Finishing 66: 58–61.
  • Schuurman, H. J., van Loveren, H., Rozing, J., and Vos, J. G. 1992. Chemicals trophic for the thymus: Risk for immunodeficiency and autoimmunity. Int. J. Immunopharmacol. 14:369–375.
  • Seinen, W., and Penninks, A. H. 1979. Immune depression as a consequence of a selective cytotoxic activity of certain organometallic compounds on thymus-dependent lymphocytes. Ann. NY. Acad. Sci. 320:499–517.
  • Snoeij, N. J., Penninks, A. H., and Seinen, W. 1987. Biological activity of organotin compounds -an overview. Environ. Res. 44:335–353.
  • Snoeij, N. J., Penninks, A. H., and Seinen, W. 1988. Dibutyltin and tributyltin compounds induce thymus atrophy in rats due to a selective action on thymic lymphoblasts. Int. J. Immunopharmacol. 10:891–899.
  • Stridh, H., Orrenius, S., and Hampton, M. B. 1999. Caspase involvement in the induction by the environmental toxicants tributyltin and triphenyltin. Toxicol. Appl. Pharmacol. 156:141–146.
  • Svitkina, T. M., Verkhovsky, A. B., and Borisy, G. G. 1996. Plectin sidearms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton. J. Cell Biol. 135:991–1007.
  • Takashi, S., Isao, Y., Hisashi, Y., Nahoko, K., Kazunari, K., and Mitsunori, M. 1998. Accumulation, metabolism, and depuration of organotin compounds in the marine mussels Mytilus graynus and Mytilus edulis under natural conditions. J. Agric. Food Chem. 46:304–313.
  • Tanaka, K., Koga, Y., Taniguchi, K., and Nomoto, K. 1987. T-cell recruitment from the thymus to the spleen in tumor bearing mice: Phenotypical alteration and recruitment of thymocytes raised in a tumor bearing state. Cancer Res. 47:2136–2141.
  • Thompson, P. M., Gotoh, T., Kok, M., White, P. S., and Brodeur, G. M. 2003. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system. Oncogene 22:1002–1011.
  • Tong, J. K., Hassig, C. A., Schnitzler, G. R., Kingston, R. E., and Schreiber, S. L. 1998. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 395:917–921.
  • Van der Kerk, G. J. 1976. Organotin compounds: past, present and future. In: Organotin Compounds: New Chemistry and Applications (Zuckermann, J. J., Ed.), Washington, DC: American Chemical Society, pp. 1–25.
  • Van Loveren, H., Krajnc, E. I., Rombout, P. J., Blommaert, F. A., and Vos, J. G. 1990. Effects of ozone, hexachlorobenzene, and bis(tri-n-butyltin)oxide on natural killer activity in the rat lung. Toxicol. Appl. Pharmacol. 102:21–33.
  • Vandebriel, R.J., Spiekstra, S.W., Hudspith, C.M., and van Loveren, H. 1999. In vitro exposure effects of cyclosporine A and bis(tri-n-butyltin)oxide on lymphocyte proliferation, cytokine (receptor) mRNA expression, and cell surface marker expression in rat thymocytes and splenocytes. Toxicology 135:49–66.
  • Vos, J. G., De Klerk, A., Krajnc, E. I., Kruzinga, W., van Ommen, B., and Rozing, J. 1984. Toxicity of bis(tri-n-butyltin) oxide in the rat II. Suppression of thymus-dependent immune responses and of parameters of non-specific resistance after short-term exposure. Toxicol. Appl. Pharmacol. 75:387–407.
  • Vos, J. G., De Klerk, A., Krajnc, E. I., van Loveren, H., and Rozing, J. 1990. Immunotoxicity of bis(tri-n-butyltin)oxide in the rat: effects on thymus dependent immunity and on non-specific resistance following long-term exposure in young versus aged rats. Toxicol. Appl. Pharmacol. 105:144–155.
  • Wykretowicz, A., Munzig, E., Garbin, F., Schulze-Forster, K., Eckert, K., and Maurer, H. R. 1994. Prothymosin-α1 stimulates selected functions of human polymorphonuclear neutrophils. Int. J. Thymol. 2:196–201.
  • Yang, H., Zhuo, J., Ochs, R. L., Henning, D., Jin, R., and Valdez, B. C. 2003. Down-regulation of RNA Helicase II/Gu results in the depletion of 18 and 28S rNAs in Xenopus oocyte. J. Biol. Chem. 278:38847–38859.
  • Yates, J. R., Eng, J. K., McCormack, A. L., and Schieltz, D. 1995. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal. Chem. 67:1426–1436.
  • Yoo, B. C., Vikolinsky, R., Engidawork, E., Cairns, N., Fountoulakis, M., and Lubec, G. 2001. Differential expression of molecular chaperones in brain of patients with Down Syndrome. Electrophoresis 22:1233–1241.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.